- Quote, Chart, News
- Snapshot
- Company Report
- Quotes
- Charts
- Key Developments
Recent News- Research
- SEC Filings
- Advisor FYI
- CAPS
- StockScouter
- Earnings Estimates
- Analyst Ratings
- Financial Results
- Insider Trading
- Ownership
- Message Board
- Guided Research
- Research Wizard
- Find Stocks
- Stock Screener
- Stock Power Searches
- Top-Rated Stocks
- Related Links
- Quote Watchlist
- Expert Picks
- E-mail & Alerts
- IPO Center
- Message Boards
- Capital Gains Analysis
News resources
| Incyte Corp (INCY) | 2 stories... |
| American International Group Inc (AIG) | 2 stories... |
| LM Ericsson Telephone ADR Reptg 1 Ord Shs Class B (ERIC) | 2 stories... |
| New York Times Co (NYT) | 1 story... |
| Ford Motor Co (F) | 1 story... |
| advertisement |
Supergen Inc: All Recent News
- Today's 5-Star Movers 11/11/2009
- Maybe what glitters really is gold. At Motley Fool
- SuperGen to Present at Lazard Healthcare Conference on... 11/11/2009
- SuperGen, Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.J. Manuso, Ph.D., President and Chief... Business Wire
- SuperGen Presentations at AACR-NCI-EORTC 11/9/2009
- SuperGen, Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced the acceptance of seven abstracts for poster... Business Wire
- SuperGen to Present at Merriman Curhan Ford Investor Summit on... 11/4/2009
- SuperGen, Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that Mohammad Azab, M.D., Chief Medical Officer, will... Business Wire
- 5-Star Stocks on the Upswing 11/2/2009
- Check out these newly minted five-star stocks. At Motley Fool
- SuperGen Reports 2009 Third Quarter Financial Results 10/26/2009
- SuperGen, Inc. (NASDAQ:SUPG) today reported financial results for the third quarter and nine months ended September 30, 2009. Total revenues for the 2009 third quarter were $10.4 million, compared... Business Wire
- SuperGen signs cancer-drug deal with Glaxo, shares rise 10/26/2009
- ... At Thomson Reuters
- Trading Outlook for Peregrine Pharmaceuticals Issued by... 10/26/2009
- DALLAS, Oct. 26, 2009 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring anti-cancer and antiviral drug developer Peregrine Pharmaceuticals (Nasdaq:PPHMD). The report includes financial and investment analysis, analyst consensus, and pertinent industry information you need to know to make an educated investment decision. GlobeNewswire
- SuperGen receiving $5 million in Glaxo deal 10/26/2009
- DUBLIN, Calif. (AP) - Drug developer SuperGen Inc. said Monday it will receive an initial payment of $5 million, plus a chance for millions more in future payments, under a deal to develop possible cancer therapies with GlaxoSmithKline. Associated Press
- SuperGen, GlaxoSmithKline sign collaboration deal 10/26/2009
- LONDON (MarketWatch) -- SuperGen Inc. said it has signed a multi-year collaboration deal with GlaxoSmithKline to discover and develop cancer therapeutics based on epigenetic targets. SuperGen will progress candidate compounds through to early clinical proof of concept. GlaxoSmithKline will then have the right to exercise an option to develop further and commercialize resulting products on a global basis. SuperGen will receive $5 million upfront, inclusive of a $3 million common stock investment. Total potential development and commercializationmilestones payable to SuperGen could exceed... At MarketWatch
- SuperGen and GSK to Collaborate on the Discovery and... 10/26/2009
- SuperGen, Inc. (NASDAQ:SUPG) and GlaxoSmithKline (NYSE:GSK) have entered into a multi-year collaboration to discover and develop cancer therapeutics based on epigenetic targets. Epigenetics refers... Business Wire
- SuperGen to Present at BIO Investor Forum on October 29, 2009 10/22/2009
- SuperGen, Inc. (Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.J. Manuso, Ph.D., President and Chief... Business Wire
- SuperGen to Announce 2009 Third Quarter Financial Results... 10/19/2009
- SuperGen Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that it will release its 2009 third quarter financial... Business Wire
- SuperGen to Present at UBS Life Sciences Conference at New... 9/22/2009
- SuperGen, Inc. (Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.J. Manuso, Ph.D., President and Chief... Business Wire
- David Bearss Resigns as Chief Scientific Officer to Join... 9/21/2009
- SuperGen Inc. (Nasdaq:SUPG) announced that, effective October 16, 2009, David Bearss, Ph.D., will resign as SuperGen’s Chief Scientific Officer, and be engaged as a long-term biology consultant to... Business Wire
- More News
- Market Report
- News by Symbol
- Today's Investing Articles
- Breaking News
- News by Topic
- News by Industry
- MSNBC News
- Data providers
- Copyright © 2009 Thomson Reuters. Click for Restrictions.
- Quotes supplied by Interactive Data Real-Time Services.